Orthofix Medical Inc. (OFIX) – What Are Analysts Saying About This Stock?

Shares of Orthofix Medical Inc. (NASDAQ:OFIX – Get Free Report) have received an average recommendation of “Hold” from the five analysts that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year target price among brokers that have covered the stock in the last year is $14.75.

OFIX has been the topic of several recent analyst reports. Weiss Ratings lowered shares of Orthofix Medical from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, November 3rd. Canaccord Genuity Group lowered their price target on Orthofix Medical from $18.00 to $13.00 and set a “buy” rating on the stock in a research report on Monday, August 10th. Finally, TD Cowen reissued a “hold” rating on shares of Orthofix Medical in a report on Tuesday.

View Our Latest Stock Report on Orthofix Medical

Orthofix Medical Trading Up 0.8%

NASDAQ OFIX opened at $7.18 on Thursday. The company has a market capitalization of $292.46 million, a PE ratio of -6.41 and a beta of 0.66. The company has a fifty day moving average of $9.16 and a 200 day moving average of $10.89. Orthofix Medical has a 1 year low of $6.52 and a 1 year high of $16.42. The company has a debt-to-equity ratio of 0.55, a current ratio of 3.11 and a quick ratio of 1.67.

Orthofix Medical (NASDAQ:OFIX – Get Free Report) last released its quarterly earnings data on Monday, November 9th. The medical device company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.11. Orthofix Medical had a negative return on equity of 10.32% and a negative net margin of 5.39%. The business had revenue of $207.86 million during the quarter, compared to analyst estimates of $210.52 million. Research analysts forecast that Orthofix Medical will post -1.29 earnings per share for the current year.

Institutional Trading of Orthofix Medical

Several institutional investors have recently modified their holdings of OFIX. R Squared Ltd increased its stake in shares of Orthofix Medical by 7.2% during the first quarter. R Squared Ltd now owns 13,518 shares of the medical device company’s stock worth $155,000 after purchasing an additional 904 shares in the last quarter. State of Wyoming increased its stake in Orthofix Medical by 12.2% during the 1st quarter. State of Wyoming now owns 14,873 shares of the medical device company’s stock worth $171,000 after buying an additional 1,617 shares in the last quarter. Parallel Advisors LLC increased its stake in Orthofix Medical by 2,434.1% during the 3rd quarter. Parallel Advisors LLC now owns 3,269 shares of the medical device company’s stock worth $31,000 after buying an additional 3,140 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new stake in Orthofix Medical during the 2nd quarter worth approximately $30,000. Finally, Legal & General Group Plc acquired a new position in shares of Orthofix Medical during the second quarter valued at approximately $37,000. Institutional investors and hedge funds own 89.76% of the company’s stock.

About Orthofix Medical

(Get Free Report)

Orthofix Medical Inc. develops and markets medical technologies for spine and orthopedic care. Its products include spinal implants and biologics, bone growth stimulation systems, and solutions used in fracture treatment and limb reconstruction. The company serves hospitals, surgeons, and other health care providers through its Orthofix and SeaSpine businesses. Its offerings span surgical products as well as noninvasive and specialized orthopedic treatments. Orthofix and SeaSpine completed a merger in 2023, combining their spine and orthopedic product portfolios.

See Also

Analyst Recommendations for Orthofix Medical (NASDAQ:OFIX)

Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with MarketBeat.com's FREE daily email newsletter.